Does low vitamin B12 impair key enzymes and raise homocysteine and methylmalonic acid?

Vitamin B12 is an essential micronutrient that serves as a high-affinity cofactor for the only two cobalamin-dependent enzymes in humans: cytosolic methionine synthase and mitochondrial methylmalonyl-CoA mutase (MCM). Intracellular B12 deficiency leads to cofactor starvation, halting these vital metabolic pathways and triggering both hematologic and neurological pathology.

Mechanistic explanations

• The Methionine Synthase Pathway and Folate Trap: Methionine synthase requires methylcobalamin to catalyze the remethylation of homocysteine to methionine. Impairment of this enzyme blocks this metabolic pathway, causing an accumulation of upstream homocysteine in the plasma. This block also traps folate as 5-methyl-tetrahydrofolate, depleting the active tetrahydrofolate pools necessary for thymidylate and DNA synthesis.
• The Methylmalonyl-CoA Mutase Pathway: MCM requires adenosylcobalamin to isomerize methylmalonyl-CoA to succinyl-CoA. When MCM activity is impaired due to low B12, methylmalonyl-CoA and its byproduct, methylmalonic acid (MMA), accumulate in the serum, urine, and cerebrospinal fluid.

Clinical and effectiveness evidence

• Megaloblastic Anemia: Impaired DNA synthesis in the bone marrow—driven by the folate trap—delays nuclear maturation relative to cytoplasmic development. This cellular dyssynchrony in erythroid precursors leads to macrocytic, megaloblastic anemia.
• Cognitive Symptoms: Elevated MMA disrupts lipid metabolism, leading to the synthesis of abnormal fatty acids that incorporate into and destabilize the myelin sheath. This demyelination in the central nervous system, coupled with homocysteine-induced microvascular damage and reduced methionine-dependent methylation, drives the white matter changes and synaptic dysfunction responsible for cognitive decline. Because these two pathways are enzymatically distinct, severe cognitive symptoms can occur even in the complete absence of anemia.

Bottom line

Low vitamin B12 impairs methionine synthase and methylmalonyl-CoA mutase. This dual enzymatic block elevates homocysteine and methylmalonic acid, causing megaloblastic anemia (via DNA synthesis failure) and cognitive decline (via demyelination and white matter damage).